company background image
CLAS

Claritas Pharmaceuticals TSXV:CLAS Stock Report

Last Price

CA$0.025

Market Cap

CA$944.7k

7D

0%

1Y

-90.4%

Updated

04 Oct, 2022

Data

Company Financials
CLAS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health3/6
Dividends0/6

CLAS Stock Overview

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.

Claritas Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Claritas Pharmaceuticals
Historical stock prices
Current Share PriceCA$0.025
52 Week HighCA$0.28
52 Week LowCA$0.025
Beta2.59
1 Month Change0%
3 Month Change0%
1 Year Change-90.39%
3 Year Change-96.43%
5 Year Change-98.96%
Change since IPO-99.86%

Recent News & Updates

Shareholder Returns

CLASCA PharmaceuticalsCA Market
7D0%1.3%5.7%
1Y-90.4%-64.8%-2.5%

Return vs Industry: CLAS underperformed the Canadian Pharmaceuticals industry which returned -64.4% over the past year.

Return vs Market: CLAS underperformed the Canadian Market which returned -4% over the past year.

Price Volatility

Is CLAS's price volatile compared to industry and market?
CLAS volatility
CLAS Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement12.8%
Market Average Movement10.1%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market3.8%

Stable Share Price: Insufficient data to determine CLAS's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine CLAS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aBob Farrellhttps://claritaspharma.com

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.

Claritas Pharmaceuticals, Inc. Fundamentals Summary

How do Claritas Pharmaceuticals's earnings and revenue compare to its market cap?
CLAS fundamental statistics
Market CapCA$944.66k
Earnings (TTM)CA$2.45m
Revenue (TTM)n/a

0.4x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CLAS income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other Expenses-US$1.80m
EarningsUS$1.81m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.048
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio16.4%

How did CLAS perform over the long term?

See historical performance and comparison